Menu
Mon panier

En cours de chargement...

Recherche avancée

Cases from the Psychiatry Letter - II - Cases from the Psychiatry Letter, #2

Edition en anglais

  • Relay Publishing

  • Paru le : 30/09/2019
Following up on volume 1, eleven more cases from the monthly Psychiatry Letter are provided in this ebook. Each case is provided with recommendations... > Lire la suite
0,99 €
E-book - ePub
Vérifier la compatibilité avec vos supports
Following up on volume 1, eleven more cases from the monthly Psychiatry Letter are provided in this ebook. Each case is provided with recommendations for an approach consistent with the PL philosophy and with links to further explanations on the PL website or to scientific articles. Case 1. Ending suicidality by stopping antidepressants in supposed borderline personalityCase 2. Life events, not traumaCase 3.  A  mixed depressive suicideCase 4.
 Your treatment is as good as your diagnosisCase 5.  Adolescent bipolar illnessCase 6. When it's okay to prescribe benzodiazepinesCase 7.  Stopping antidepressants for "depression"Case 8. Carbamazepine to the rescueCase 9.  Hyperthymic temperamentCase 10. Treating anxiety symptoms in PTSDCase 11.  Preadolescent depression versus bipolar illness

Fiche technique

  • Caractéristiques du format ePub
    • Protection num. : pas de protection

À propos de l'auteur

Biographie de Nassir Ghaemi

S. Nassir Ghaemi MD MPH is a psychiatrist and author. He is Professor of Psychiatry at Tufts University and Lecturer on Psychiatry at Harvard Medical School. He has published multiple academic books, including Clinical Psychopharmacology (Oxford University Press, 2019), and is author of A First-Rate Madness: Exploring the LInks between Mental Illness and Leadership (Penguin, 2011), a New York Times bestseller.
He has published over 200 scientific articles, over 50 book chapters, and is a peer reviewer for many scientific journals, as well as Associate Editor of Acta Psychiatrica ScandinavicaDisclosure: Since 2017, Dr. Ghaemi also has been employed at Novartis Institutes for Biomedical Research in Cambridge, MA as a director of early drug discovery research in psychiatry. The views expressed here are his alone, and do not necessarily reflect those of any of his employers. 
Cases from the Psychiatry Letter - II. Cases...
0,99 €
Haut de page